한글목차

피부사상균성 손발톱진균증 치료 시장은 2026년에 72억 9,660만 달러로 추정되며, 2033년까지 122억 1,970만 달러에 달할 것으로 예측됩니다. 2026년부터 2033년까지 연평균 성장률(CAGR) 7.6%로 전망됩니다.

손발톱진균증은 Trichophyton rubrum(Trichophyton rubrum)과 Trichophyton mentagrophytes(Trichophyton mentagrophytes)에 의한 곰팡이 감염이며, 경우에 따라서는 효모균이나 곰팡이가 원인이 되기도 합니다. 손발톱진균증 감염의 주요 요인은 벌레와 습한 환경에 노출될 기회가 많아지면서 곰팡이가 번식하기에 최적의 조건을 조성하는 것입니다. 손발톱진균증의 주요 증상으로는 손톱 밑에 생기는 흰색이나 노란색 반점으로 인한 변색, 손톱이 두꺼워지고 손톱의 가장자리가 무너지는 증상 등이 있습니다.

본 조사의 주요 특징

• 이 보고서는 세계 피부사상균성 손발톱진균증 치료 시장에 대한 상세한 분석을 제공하며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년)의 시장 규모와 예측 기간(2026-2033년)의 연평균 성장률(CAGR)을 제시합니다.
• 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명할 것입니다.
• 시장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
• 이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략, 미래 계획과 같은 매개 변수를 기반으로 세계 피부사상균성 손발톱진균증 치료 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내리는 데 도움이 될 것입니다.
• 이 세계 피부사상균성 손발톱진균증 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 피부사상균성 손발톱진균증 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.

목차

제1장 조사 목적과 가정

제2장 시장 범위

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 피부사상균성 손발톱진균증 치료 시장 : 제품 유형별, 2026-2033년

제5장 세계의 피부사상균성 손발톱진균증 치료 시장 : 치료법별, 2026-2033년

제6장 세계의 피부사상균성 손발톱진균증 치료 시장 : 최종사용자별, 2026-2033년

제7장 세계의 피부사상균성 손발톱진균증 치료 시장 : 지역별, 2026-2033년

제8장 경쟁 구도

제9장 섹션

영문목차

Dermatophytic Onychomycosis Treatment Market is estimated to be valued at USD 7,296.6 Mn in 2026 and is expected to reach USD 12,219.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Nail onychomycosis is a fungal infection is caused by a trichophyton rubrum, trichophyton mentagrophytes, and in some cases it is caused by yeasts and molds. The major factors responsible for nail onchomycosis infection is increased exposure to worm and moist environment which leads to perfect condition for fungus to grow and proliferate. The major symptoms of onychomycosis comprises of white and yellow spots under the nail leading to discoloration, nail thickening, and formation of crumbling edges on the nail.

Key features of the study

• This report provides in-depth analysis of the global dermatophytic onychomycosis treatment market and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global dermatophytic onychomycosis treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Anacor Pharmaceuticals, Inc., NovaQuest Capital Management, L.L.C., and Novan, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global dermatophytic onychomycosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatophytic onychomycosis treatment market

Market Segmentation

• By Product Type
  • Tablets
  • Nail Paints
• By Treatment
  • Oral
  • Topical
• By End User
  • Hospitals
  • Clinics
  • Independent Pharmacies
  • Mail Order Pharmacies
  • Drug Stores
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Global Dermatophytic Onychomycosis Treatment Market: Competitive Landscape
  • Valeant Pharmaceuticals International Inc.
  • Galderma S.A.
  • Novartis AG
  • Pfizer Inc.
  • Moberg Pharma AB
  • Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
  • Anacor Pharmaceuticals, Inc.
  • NovaQuest Capital Management, L.L.C.
  • Novan, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Treatment
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Reimbursement Scenario
• Merger and Acquisition Scenario
• PEST Analysis

4. Global Dermatophytic Onychomycosis Treatment Market, By Product Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2019 and 2033 (%)
  • Y-o-Y Growth Analysis, 2017 - 2033
  • Segment Trends
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Nail Paints
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Dermatophytic Onychomycosis Treatment Market, By Treatment, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2019 and 2033 (%)
  • Y-o-Y Growth Analysis, 2017 - 2033
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Dermatophytic Onychomycosis Treatment Market, By End User, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2019 and 2033 (%)
  • Y-o-Y Growth Analysis, 2017 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Independent Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Mail Order Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Drug Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Dermatophytic Onychomycosis Treatment Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2019 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2033
• North America
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Valeant Pharmaceuticals International Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Galderma S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Moberg Pharma AB
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Anacor Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • NovaQuest Capital Management, L.L.C.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Novan, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

9. Section

• References
• Research Methodology
• About Us and Sales Contact